![]() |
New Patient Study Suggests Siemens Non-Invasive Blood Test May Have a Role in Monitor
Siemens Healthcare ( www.siemens.com/diagnostics ) announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer.
More... |
| All times are GMT -7. The time now is 05:20 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021